Stockreport

Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program [Canadian Business Journal (Canada)]

Psyence Biomedical Ltd. - Ordinary Shares  (PBM) 
PDF First publicly listed company to actively investigate psilocybin’s potential impact on longevityNEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasda [Read more]